Professur für Hämatologie/Onkologie mit dem Schwerpunkt Tumorimmunologie

Adresse:
Ulmenweg 18
91054 Erlangen


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 2 Go to next page Go to last page

Haug, T., Aigner, M., Peuser, M.M., Strobl, C., Hildner, K., Mougiakakos, D.,... Völkl, S. (2019). Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity. Frontiers in Immunology, 10. https://dx.doi.org/10.3389/fimmu.2019.00883
Bruns, H., Jitschin, S., Gamali, S., Saul, D., Böttcher, M., Mackensen, A.,... Mougiakakos, D. (2019). A novel immunoregulatory function of beta-2-microglobulin as a promoter of myeloid derived suppressor cell induction. Leukemia. https://dx.doi.org/10.1038/s41375-018-0345-0
Jitschin, R., Böttcher, M., Saul, D., Lukassen, S., Bruns, H., Loschinski, R.,... Mougiakakos, D. (2019). Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation. Leukemia. https://dx.doi.org/10.1038/s41375-018-0376-6
Chaturvedi, A., Cruz, M.M.A., Goparaju, R., Gabdoulline, R., Schottmann, R., Goerlich, K.,... Heuser, M. (2018). Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Böttcher, M., Panagiotidis, K., Mackensen, A., & Mougiakakos, D. (2018). Stroma Cells Promote a S100A8/A9(high)-Subset of AML Blasts with Distinct Metabolic Features in a Jak/STAT3-Dependent Manner. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Bach, C., Leffler, M., Flamann, C., Kronke, J., Mougiakakos, D., Mackensen, A., & Bruns, H. (2018). Role of N6-Methyladenosine (m6A) RNA Modification in Multiple Myeloma. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Schwab, A., Siddiqui, A., Vazakidou, M.E., Napoli, F., Böttcher, M., Menchicchi, B.,... Ceppi, P. (2018). Polyol pathway links glucose metabolism to the aggressiveness of cancer cells. Cancer Research. https://dx.doi.org/10.1158/0008-5472.CAN-17-2834
Urbanczyk, S., Stein, M., Stein, M., Schuh, W., Jäck, H.-M., Mougiakakos, D., & Mielenz, D. (2018). Regulation of Energy Metabolism during Early B Lymphocyte Development. International Journal of Molecular Sciences, 19(8). https://dx.doi.org/10.3390/ijms19082192
Loschinski, R., Böttcher, M., Stoll, A., Bruns, H., Mackensen, A., & Mougiakakos, D. (2018). IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner. Oncotarget, 9(17), 13125-13138. https://dx.doi.org/10.18632/oncotarget.24442
Lucas, S., Omata, Y., Hofmann, J., Böttcher, M., Iljazovic, A., Sarter, K.,... Zaiss, M. (2018). Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nature Communications, 9(1), 55. https://dx.doi.org/10.1038/s41467-017-02490-4
Jitschin, R., Saul, D., Braun, M., Tohumeken, S., Völkl, S., Kischel, R.,... Mougiakakos, D. (2018). CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. Journal for ImmunoTherapy of Cancer, 6(1). https://dx.doi.org/10.1186/s40425-018-0432-9
Iacobaeus, E., Douagi, I., Jitschin, R., Marcusson-Stahl, M., Andren, A.T., Andren, A.T.,... Le Blanc, K. (2018). Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis. Immunology and Cell Biology, 96(8), 820-830. https://dx.doi.org/10.1111/imcb.12042
Böttcher, M., Renner, K., Berger, R., Mentz, K., Thomas, S., Cardenas-Conejo, Z.E.,... Mougiakakos, D. (2018). D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization. OncoImmunology, 7(7). https://dx.doi.org/10.1080/2162402X.2018.1445454
Busch, L., Mougiakakos, D., Büttner-Herold, M., Müller, M.J., Volmer, D.A., Bach, C.,... Bruns, H. (2018). Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway. Leukemia. https://dx.doi.org/10.1038/s41375-018-0114-0
Lucas, S., Omata, Y., Böttcher, M., Hofmann, J., Krishnacoumar, B., Krönke, G.,... Zaiss, M. (2017). Short chain fatty acids are potent regulators of systemic bone mass and protect for pathological bone loss by inhibiting osteoclasts. European Journal of Immunology, 47, 217-217.
Urbanczyk, S., Stein, M.F., Duetting, S., Mougiakakos, D., Boesl, M., Reimer, D.,... Mielenz, D. (2017). Influence of Swiprosin2/EFhd1 on the metabolic control of B cell differentiation and humoral immunity. (pp. 96-96).
Krebs, A.M., Mitschke, J., Losada, M.L., Schmalhofer, O., Boerries, M., Busch, H.,... Pilarsky, C. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nature Cell Biology, 19(5), 518-529. https://dx.doi.org/10.1038/ncb3513
Kravic, B., Harbauer, A.B., Romanello, V., Simeone, L., Vögtle, F.N., Kaiser, T.,... Hashemolhosseini, S. (2017). In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy. Autophagy, 1-65. https://dx.doi.org/10.1080/15548627.2017.1403716
Qorraj, M., Böttcher, M., & Mougiakakos, D. (2017). PD-L1/PD-1: new kid on the "immune metabolic" block. Oncotarget, 8(43), 73364-73365. https://dx.doi.org/10.18632/oncotarget.20639
Steven, A., Leisz, S., Wickenhauser, C., Schulz, K., Mougiakakos, D., Kiessling, R.,... Seliger, B. (2017). Linking CREB function with altered metabolism in murine fibroblast-based model cell lines. Oncotarget, 8(57), 97439-97463. https://dx.doi.org/10.18632/oncotarget.22135

Zuletzt aktualisiert 2019-24-04 um 10:22